Form 144 is a required notice for affiliates like officers selling restricted securities under Rule 144 without registration. Here, Rocket Lab Corporation officer Frank Klein discloses proposed sale of 4,736 common shares (NASDAQ: RKLB) on or about November 26, 2025, via broker Morgan Stanley. Shares were acquired November 22, 2025, from issuer via Restricted Stock Units (RSUs), a standard executive compensation mechanism at growth companies like Rocket Lab, which focuses on space launch and satellite services. The filing notes reliance on a pre-established Rule 10b5-1 trading plan from December 13, 2024, designed to avoid insider trading allegations by scheduling sales in advance. Recent sales by Klein include 41,782 shares on November 24, 2025 ($1,698,509), 4,286 on September 17, 2025 ($204,524), and 45,535 on September 16, 2025 ($2,229,743), totaling ~95,539 shares proposed including this (~$4.33M gross). With 534M shares outstanding, this is negligible ownership impact. Klein certifies no undisclosed material adverse info.

Routine insider sale tied to RSU vesting under pre-planned 10b5-1 mitigates concerns over timing or MNPI. Minimal near-term impact on stock price or valuation given tiny fraction (~0.0009%) of outstanding shares and pattern of compensation liquidity. Strategic non-event for Rocket Lab investors; monitor aggregate insider selling trends and upcoming launches/earnings for business momentum.